The Biosynthesis of Cannabinoids
Posted 6th May 2020 by Joshua Sewell
We recently spoke to Jeremy Friedberg, CSO of LAVVAN, a company pioneering the biosynthesis of cannabinoids. The conversation was recorded as a podcast, which can be found here.
The case for biosynthesis: 5 problems with cannabinoids derived from plant cultivation
Posted 25th February 2020 by Joshua Sewell
As we look at the current and future market demands for cannabinoid ingredients, large consumer buyers are focused on purity, consistency and stability of supply. For a host of reasons, cannabinoid suppliers will find it extraordinarily difficult to meet this demand with plant-based production systems.